کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
8808750 | 1606739 | 2018 | 9 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Calendario de vacunaciones de la Asociación Española de PediatrÃa (CAV-AEP): recomendaciones 2018
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
immunisation schedule - برنامه ایمن سازیCalendario de vacunación - برنامه واکسیناسیونEnfermedades inmunoprevenibles - بیماری های ایمن شناخته شدهVaccine preventable diseases - بیماری های قابل پیشگیری در واکسنAdolescentes - نوجوانAdolescents - نوجوانیVaccines - واکسنVacunas - واکسنChildren - کودکانNiños - کودکان
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
پریناتولوژی (پزشکی مادر و جنین)، طب اطفال و بهداشت کودک
پیش نمایش صفحه اول مقاله
چکیده انگلیسی
The Advisory Committee on Vaccines of the Spanish Association of Paediatrics annually publishes the immunisation schedule considered optimal for children resident in Spain, according to available evidence on current vaccines. Regarding funded immunisations, 2+1 strategy (2, 4, 11-12 months) with hexavalent (DTPa-IPV-Hib-HB) and 13-valent pneumococcal vaccines are recommended. Administration of the 6-year booster dose with DTPa is recommended, and a poliomyelitis dose for children who had received the 2+1 scheme, as well as Tdap vaccine for adolescents and pregnant women in every pregnancy between 27 and 32 weeks' gestation. The two-dose scheme should be used for MMR (12 months and 2-4 years) and varicella (15 months and 2-4 years). MMRV vaccine could be applied as the second dose if available. Coverage of human papillomavirus vaccination in girls aged 12 with a two dose scheme (0, 6 months) should be improved. Information and recommendation for male adolescents about potential beneficial effects of this immunisation should be provided as well. The new 9 genotypes vaccine is now available, expanding the coverage for both gender. Regarding non-funded immunisations, Committee on Vaccines of the Spanish Association of Paediatrics recommends meningococcal B vaccination, with a 3+1 schedule, and requests to be included in the National Immunisation Program. Tetravalent meningococcal vaccine (MenACWY) is recommended to adolescents (14-18 years) who are going to live in countries with systematic vaccination against ACWY serogroups, and people >6 weeks of age with risk factors or travellers to countries with very high incidence. Vaccination against rotavirus is recommended in all infants.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Anales de PediatrÃa - Volume 88, Issue 1, January 2018, Pages 53.e1-53.e9
Journal: Anales de PediatrÃa - Volume 88, Issue 1, January 2018, Pages 53.e1-53.e9
نویسندگان
David Moreno-Pérez, Francisco José Álvarez GarcÃa, Javier Álvarez Aldeán, MarÃa José Cilleruelo Ortega, MarÃa Garcés Sánchez, Nuria GarcÃa Sánchez, Ángel Hernández Merino, MarÃa Méndez Hernández, Manuel Merino MoÃna,